XTL BIOPHARMACEUTICALS LTDICAN DEPOSITARY SHARES

(Delisted)

Share · US98386D3070 · XTLB · A2DK34 (XNCM)

This security is no longer traded.

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of XTL BIOPHARMACEUTICALS LTDICAN DEPOSITARY SHARES

No Price

28.04.2026 20:00

Current Prices from XTL BIOPHARMACEUTICALS LTDICAN DEPOSITARY SHARES

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	XTLB	USD	28.04.2026 20:00	2,30 USD	-0,09 USD -3,77 %
IEX	XTLB	USD	28.04.2026 15:37	2,32 USD	-0,07 USD -2,93 %

Company Profile for XTL BIOPHARMACEUTICALS LTDICAN DEPOSITARY SHARES Share

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.